Lorazepam Injection, Solution
Product Images NDC 0409-1985

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lorazepam (NDC 0409-1985). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lorazepam 01)

FDA Label Image

Lorazepam 01a

FDA Label Image

Logo (Lorazepam 02)

FDA Label Image

Principal Display Panel (4 mg/mL Cartridge Label)

Principal Display Panel (4 mg/mL Cartridge Label)
This text describes a medication called Lorazepam, which comes in a sterile cartridge unit with a Luer Lock attachment for intramuscular or intravenous use. The medication should be diluted before intravenous use and must be protected from light. The medication is distributed by Hospira, Inc. in Lake Forest, IL, and the packaging includes an NDC number, lot number, and expiration date.*
FDA Label Image

Principal Display Panel (4 mg/mL Cartridge Carton)

Principal Display Panel (4 mg/mL Cartridge Carton)
This is a product package for Carpuject™ Sterile Cartridge Units that contain Lorazepam Injection, USP. Each cartridge contains 4mg/mL of Lorazepam Injection which can be used for intramuscular or intravenous purposes. The cartridge units are designed to be used with Carpuject holders and come with Luer Lock. The package contains ten sterilized cartridge units and does not include a needle. It is manufactured in Italy and distributed in the USA by Hospira Inc. The instructions recommend keeping the product refrigerated between 2°C to 8°C, away from light, and prevent use if the solution appears discolored or contains a precipitate.*
FDA Label Image

Principal Display Panel (2 mg/mL Cartridge Label)

Principal Display Panel (2 mg/mL Cartridge Label)
This is a description of a medical product called TmL Single-dose Carpuject. It is a sterile cartridge unit for intramuscular or intravenous use containing lidocaine injection. It has a Luer Lock and is intended for prescription only. The text also provides instructions on diluting the solution before intravenous use and storing the product.*
FDA Label Image

Principal Display Panel (2 mg/mL Cartridge Carton)

Principal Display Panel (2 mg/mL Cartridge Carton)
This appears to be a product description of a medical cartridge unit for administering Lorazepam in either intramuscular or intravenous use. The text contains instructions and guidelines for the correct use and storage of the cartridges. The products are distributed by a company called Hospira, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.